CETP inhibitor (Sandoz)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCETP inhibitor (Sandoz)
Drug Alias Namecholesterol ester transfer protein inhibitor (Sandoz)atherosclerosis therapies (Sandoz)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesteryl ester transfer protein inhibitors
TargetsCholesteryl ester transfer protein
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSandoz Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSandoz Ag
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipidemiasAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A